SP1 and non-small cell lung carcinoma: Taken together, we hypothesized that SP1 promoted Syncytin1 expression and knockdown of SP1/Syncytin1 axis inhibited the proliferation and metastasis through the AKT signaling pathway in human NSCLC cells.